Yıl: 2023 Cilt: 8 Sayı: 1 Sayfa Aralığı: 115 - 121 Metin Dili: İngilizce DOI: 10.26453/otjhs.1217364 İndeks Tarihi: 15-03-2023

Cytotoxic Effects of Cisplatin and Carboplatin Loaded Albumin Nanoparticles on Breast Cancer Cells

Öz:
Objective: This study aims to investigate and compare the anticancer effects of carboplatin and cisplatin, frequently used in cancer treatment, by loading them on albumin nanocarrier. Materials and Methods: Carboplatin (CP) and Cisplatin (Cis) loaded albumin nanoparticles were synthesized using ultrasonication as CP-NPs and Cis-NPs, respectively. Nanoparticle size and distribution were evaluated by Dynamic light scattering (DLS). Cytotoxicities of NPs were evaluated in MDA-MB-231 and MCF-7 breast cancer cells and HUVEC using MTT test and their morphological images were compared. Results: While the average size of CP-NPs was around 2-3 nm, Cis-NPs was 7-8 nm. It was observed that both NPs groups were homogeneously dispersed. According to the cytotoxicity results, both CP-NPs and Cis-NPs were more cytotoxic on MCF-7 breast cancer cells. In addition, CP-NPs and Cis-NPs showed significant cytotoxicity on MCF-7, MDA-MB-231 breast cancer cells, while low cytotoxicity was detected in normal HUVEC cells. The NPs treated MCF-7 was compared with the untreated MCF-7 and statistical significance was calculated as P<0.01 for CP-NPs and Cis-NPs. Conclusions: Abumin-based CP-NPs and Cis-NPs showed high cytotoxicity in breast cancer cells, they have low cytotoxicity in healthy cells, making them promising for breast cancer treatment.
Anahtar Kelime: Cytotoxicity breast cancer MCF-7 MDA-MB-231 nano drug

Sisplatin ve Karboplatin Yüklü Albumin Nanopartiküllerin Meme Kanseri Hücreleri Üzerindeki Sitotoksik Etkileri

Öz:
Amaç: Bu çalışmanın amacı kanser tedavisinde sıklıkla kullanılan karboplatin ve sisplatin ilaçlarının albümin nanotaşıyıcıya yüklenerek antikanser etkilerinin araştırılması ve karşılaştırılmasıdır. Materyal ve Metot: Karboplatin (CP) ve Sisplatin (Cis) yüklenmiş albümin nanopartiküller, sırasıyla CP-NPs ve Cis-NPs olarak ultrasonikasyon kullanarak sentezlendi. Nanopartikül boyutu ve dağılımın homojenitesi Dinamik ışık saçılımı (DLS) ile değerlendirildi. Nanopartiküllerin sitotoksik aktiviteleri MDA-MB-231 ve MCF-7 meme kanseri hücrelerinde ve HUVEC hücrelerinde, MTT testi kullanılarak değerlendirildi ve morfolojik görüntüleri karşılaştırıldı. Bulgular: CP-NPs’lerin boyutu ortalama 2-3 nm civarında iken, Cis-NPs’lerin 7-8 nm idi. Her iki nanopartikül grubunun da homojen bir şekilde dağıldığı görüldü. Sitotoksisite sonuçlarına göre CP-NPs ve Cis-NPs, MCF-7 meme kanseri hücrelerinde daha sitotoksikti. Ayrıca CP-NPs ve Cis-NPs’ler MDA-MB-231 meme kanseri hücrelerinde önemli sitotoksisite gösterirken, normal HUVEC hücrelerinde düşük sitotoksisite tespit edildi. CP-NPs ve Cis-NPs ile tedavi edilen MCF-7, tedavi edilmeyen MCF-7 ile karşılaştırıldı ve NPs'ler için istatistiksel anlamlılık P<0,01 olarak hesaplandı. Sonuç: Meme kanseri hücrelerinde yüksek sitotoksisite gözlenirken, sağlıklı hücrelerde belirgin sitotoksisite gözlenmemiş olup albümine bağlı CP-NPs ve Cis-NPs kanser tedavisinde umut vadedici bir tedavi seçeneği olabilir.
Anahtar Kelime: MCF-7 MDA-MB-231 meme kan- seri nano ilaç sitotoksisite

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Howell A, Anderson AS, Clarke RB, et al. Risk determination and prevention of breast cancer. Breast Cancer Research 2014;16(5):1-19. doi:10.1186/S13058-014-0446-2
  • 2. Reang J, Sharma PC, Kumar Thakur V, et al. Understanding the therapeutic potential of ascorbic acid in the battle to overcome cancer. Biomolecules 2021;11(8):1130. doi:10.3390/BIOM11081130
  • 3. Schirrmacher V. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment. Int J Oncol. 2019;54(2):407-419. https://doi.org/10.3892/ijo.2018.4661
  • 4. Zhao CY, Cheng R, Yang Z, Tian ZM. Nanotechnology for cancer therapy based on chemotherapy. Molecules. 2018;23(4). doi:10.3390/molecules23040826
  • 5. Parvanian S, Mostafavi SM, Aghashiri M. Multifunctional nanoparticle developments in cancer diagnosis and treatment. Sens Biosensing Res. 2017;13:81-87. doi:10.1016/J.SBSR.2016.08.002
  • 6. Wu J. The enhanced permeability and retention (epr) effect:The significance of the concept and methods to enhance its application. Journal of Personalized Medicine 2021;11(8):771. doi:10.3390/JPM11080771
  • 7. Ma P, Mumper RJ. Paclitaxel nano-delivery systems: a comprehensive review. J Nanomed Nanotechnol. 2013;4(2):1000164. doi:10.4172/2157-7439.1000164
  • 8. Karami E, Behdani M, Kazemi-Lomedasht F. Albumin nanoparticles as nanocarriers for drug delivery: Focusing on antibody and nanobody delivery and albumin-based drugs. J Drug Deliv Sci Technol. 2020;55:101471. doi:10.1016/J.JDDST.2019.101471
  • 9. Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. Journal of Controlled Release. 2012;157(2):168-182. doi:10.1016/J.JCONREL.2011.07.031
  • 10. Lee ES, Youn YS. Albumin-based potential drugs: focus on half-life extension and nanoparticle preparation. Journal of Pharmaceutical Investigation 2016;46(4):305-315. doi:10.1007/S40005-016-0250-3
  • 11. Vaz J, Ansari D, Sasor A, Andersson R. SPARC: A Potential Prognostic and Therapeutic Target in Pancreatic Cancer. Pancreas. 2015;44(7):1024. doi:10.1097/MPA.0000000000000409
  • 12. Kratz F. A clinical update of using albumin as a drug vehicle-A commentary. Journal of Controlled Release. 2014;190:331-336. doi:10.1016/J.JCONREL.2014.03.013
  • 13. Hassanin I, Elzoghby A. Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance. Cancer Drug Resistance. 2020;3(4):930-946. doi:10.20517/CDR.2020.68
  • 14. Kalındemirtaş FD, Kariper İA, Sert E, Okşak N, Kuruca SE. The evaluation of anticancer activity by synthesizing 5FU loaded albumin nanoparticles by exposure to UV light. Toxicology in Vitro 2022;84:105435. doi.org/10.1016/j.tiv.2022.105435
  • 15. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55-63. doi:10.1016/0022-1759(83)90303-4
  • 16. Dang Y, Guan J. Nanoparticle-based drug delivery systems for cancer therapy. Smart Mater Med. 2020;1:10-19. doi:10.1016/J.SMAIM.2020.04.001
  • 17. Liu Y, Guo Q, Sun H, Guo N, Zhang J. Improved therapeutic efficiency of photothermal treatment and nursing care in prostate cancer by DOX loaded PEG coated Cu@Se nano-hybrid vesicle. Process Biochemistry. 2020;92:78-84. doi:10.1016/J.PROCBIO.2020.02.022
  • 18. Ye BL, Zheng R, Ruan XJ, Zheng ZH, Cai HJ. Chitosan-coated doxorubicin nano-particles drug delivery system inhibits cell growth of liver cancer via p53/PRC1 pathway. Biochem Biophys Res Commun. 2018;495(1):414-420. doi:10.1016/J.BBRC.2017.10.156
  • 19. Haggag YA, Osman MA, El-Gizawy SA, et al. Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer activity and ameliorates side effects in solid Ehrlich Carcinoma-bearing mice. Biomedicine & Pharmacotherapy. 2018;105:215-224. doi:10.1016/J.BIOPHA.2018.05.124
  • 20. Vijayakumar S, Ganesan S. Size-dependent in vitro cytotoxicity assay of gold nanoparticles. Toxicological & Environmental Chemistry 2013;95(2):277-287. doi:10.1080/02772248.2013.770858
  • 21. Kocak C, Kocak FE, Ozturk B, Tekin G, Vatansev H. Cytotoxic, anti-proliferative and apoptotic effects of noscapine on human estrogen receptor positive (MCF-7) and negative (MDA-MB-231) breast cancer cell lines. Bratisl Lek Listy. 2020;121(1):43-50. doi:10.4149/BLL_2020_007
  • 22. Noh JI, Mun SK, Lim EH, et al. Induction of apoptosis in MDA-MB-231 cells treated with the methanol extract of lichen physconia hokkaidensis. Journal of Fungi 2021;7(3):188. doi:10.3390/JOF7030188
  • 23. Yetisgin AA, Cetinel S, Zuvin M, Kosar A, Kutlu O. Therapeutic nanoparticles and their targeted delivery applications. Molecules. 2020;25(9). doi:10.3390/MOLECULES25092193
  • 24. Zinger A, Koren L, Adir O, et al. Collagenase nanoparticles enhance the penetration of drugs into pancreatic tumors. ACS Nano. 2019;13(10):11008-11021 doi: 10.1021/acsnano.9b02395
  • 25. Yan L, Shen J, Wang J, Yang X, Dong S, Lu S. Nanoparticle-based drug delivery system: a patient-friendly chemotherapy for oncology. Dose-Response. 2020;18(3). doi:10.1177/1559325820936161
  • 26. Edis Z, Wang J, Waqas MK, Ijaz M, Ijaz M. Nanocarriers-mediated drug delivery systems for anticancer agents: an overview and Perspectives. Int J Nanomedicine. 2021;16:1313-1330. doi:10.2147/IJN.S289443
APA Danışman F, kariper i (2023). Cytotoxic Effects of Cisplatin and Carboplatin Loaded Albumin Nanoparticles on Breast Cancer Cells. , 115 - 121. 10.26453/otjhs.1217364
Chicago Danışman Ferdane,kariper ishak afşin Cytotoxic Effects of Cisplatin and Carboplatin Loaded Albumin Nanoparticles on Breast Cancer Cells. (2023): 115 - 121. 10.26453/otjhs.1217364
MLA Danışman Ferdane,kariper ishak afşin Cytotoxic Effects of Cisplatin and Carboplatin Loaded Albumin Nanoparticles on Breast Cancer Cells. , 2023, ss.115 - 121. 10.26453/otjhs.1217364
AMA Danışman F,kariper i Cytotoxic Effects of Cisplatin and Carboplatin Loaded Albumin Nanoparticles on Breast Cancer Cells. . 2023; 115 - 121. 10.26453/otjhs.1217364
Vancouver Danışman F,kariper i Cytotoxic Effects of Cisplatin and Carboplatin Loaded Albumin Nanoparticles on Breast Cancer Cells. . 2023; 115 - 121. 10.26453/otjhs.1217364
IEEE Danışman F,kariper i "Cytotoxic Effects of Cisplatin and Carboplatin Loaded Albumin Nanoparticles on Breast Cancer Cells." , ss.115 - 121, 2023. 10.26453/otjhs.1217364
ISNAD Danışman, Ferdane - kariper, ishak afşin. "Cytotoxic Effects of Cisplatin and Carboplatin Loaded Albumin Nanoparticles on Breast Cancer Cells". (2023), 115-121. https://doi.org/10.26453/otjhs.1217364
APA Danışman F, kariper i (2023). Cytotoxic Effects of Cisplatin and Carboplatin Loaded Albumin Nanoparticles on Breast Cancer Cells. Online Türk Sağlık Bilimleri Dergisi, 8(1), 115 - 121. 10.26453/otjhs.1217364
Chicago Danışman Ferdane,kariper ishak afşin Cytotoxic Effects of Cisplatin and Carboplatin Loaded Albumin Nanoparticles on Breast Cancer Cells. Online Türk Sağlık Bilimleri Dergisi 8, no.1 (2023): 115 - 121. 10.26453/otjhs.1217364
MLA Danışman Ferdane,kariper ishak afşin Cytotoxic Effects of Cisplatin and Carboplatin Loaded Albumin Nanoparticles on Breast Cancer Cells. Online Türk Sağlık Bilimleri Dergisi, vol.8, no.1, 2023, ss.115 - 121. 10.26453/otjhs.1217364
AMA Danışman F,kariper i Cytotoxic Effects of Cisplatin and Carboplatin Loaded Albumin Nanoparticles on Breast Cancer Cells. Online Türk Sağlık Bilimleri Dergisi. 2023; 8(1): 115 - 121. 10.26453/otjhs.1217364
Vancouver Danışman F,kariper i Cytotoxic Effects of Cisplatin and Carboplatin Loaded Albumin Nanoparticles on Breast Cancer Cells. Online Türk Sağlık Bilimleri Dergisi. 2023; 8(1): 115 - 121. 10.26453/otjhs.1217364
IEEE Danışman F,kariper i "Cytotoxic Effects of Cisplatin and Carboplatin Loaded Albumin Nanoparticles on Breast Cancer Cells." Online Türk Sağlık Bilimleri Dergisi, 8, ss.115 - 121, 2023. 10.26453/otjhs.1217364
ISNAD Danışman, Ferdane - kariper, ishak afşin. "Cytotoxic Effects of Cisplatin and Carboplatin Loaded Albumin Nanoparticles on Breast Cancer Cells". Online Türk Sağlık Bilimleri Dergisi 8/1 (2023), 115-121. https://doi.org/10.26453/otjhs.1217364